Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature Medicine HONG KONG, Jan. 23, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or… January 23, 2025
J.S. Held Releases 2025 Global Risk Report Addressing Critical Risks Amid Uncertainty JERICHO, N.Y., Jan. 23, 2025 /PRNewswire/ — On the first day of… January 23, 2025
VinCSS Applauded by Frost & Sullivan for its Pioneering FIDO IoT Device Onboarding (FDO) Security and its Transformational Innovation Leadership What truly differentiates VinCSS is its ability to enable organizations, OEM manufacturers,… January 23, 2025
Discover the Perfect Blend of European French Cheeses and Spices: A Culinary Adventure for Singaporean Palates SINGAPORE, Jan. 23, 2025 /PRNewswire/ — Experience the ultimate fusion of flavors… January 23, 2025
Sunway Medical Centre named in the inaugural Newsweek's Asia's Top Private Hospitals 2025 ranking SUBANG JAYA, Malaysia, Jan. 23, 2025 /PRNewswire/ — Sunway Medical Centre, Sunway… January 23, 2025
SK hynix Announces 4Q24 Financial Results Revenues for 2024 at 66.1930 trillion won, operating profit at 23.4673 trillion… January 23, 2025
Health In Tech Announces Innovative Collaboration with MARPAI and Vitable DPC to Offer Competitive Quotes in Enhanced Self-Funded Solutions STUART, Fla., Jan. 23, 2025 /PRNewswire/ — Health In Tech, an Insurtech platform… January 23, 2025
Bright Scholar Schedules Unaudited Financial Results for the First Quarter of Fiscal 2025 Ended November 30, 2024 CAMBRIDGE, England and FOSHAN, China, Jan. 23, 2025 /PRNewswire/ — Bright Scholar… January 23, 2025
